Navigation Links
School Vaccination Program to Include Cancer Drug Gardasil

The Government of Australia has decided to include Gardasil in the national immunization program from next year. The drug is effective for treating cervical cancer. The// immunization program is expected to cover high schools from April, 2007.

All girls, between the ages of 12 and 18 will benefit from this program. All women between the ages of 18 and 26 will also be able to avail this facility through their GPs for the next two years.

The prime minister ,in a message to the public mentioned that the government is only glad to make this expensive, yet effective vaccine to the public at subsidized rates .The projected cost of the program is about $436 million, said Prime minister John Howard. The Pharmaceutical Benefits Advisory Committee (PBAC) to the Australian government had sparked of a controversy this month since it publicly stated that spending $150 million annually to vaccinate all young women in Australia was not cost effective.

This vaccine has been developed by a scientist from Australia, by the name, Ian Frazer. The drug gardasil prevents infection with human Papilloma virus .This virus is responsible for more than 70% of all cervical cancers. Cervical cancer, is responsible for the death of almost 270 Australian women, annually, divulged government officials.
MST
'"/>




Page: 1

Related medicine news :

1. Does Success in School Differ From the Real World Success ?
2. Exposure to Pesticides in Schools Produces Illnesses Among Employees, Students
3. Adolescents Who Walk To School Are Fitter, More Active
4. Popularity Among Peers Increases Susceptibility To Smoking Habit Among School Children
5. Vitamin filled nutrition candy for School children
6. A Comparative Study On Dietary Habits In Middle School Students And Increase In Weight
7. Improperly Placed And Heavy Backpacks Lead To Back Pain In School Children
8. School Children Put To Risk Due To Shortage Of Nurses
9. Sex Education, Need Of The Hour In Public Schools
10. Schools and Bars closed in Rwanda due to Cholera outbreak
11. Tuberculosis test for Westminster High School
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... ... May 24, 2017 , ... Patients who want to receive ... now meet with Dr. Joseph Bedich for a consultation, with or without a referral. ... oral health and functionality. , Dr. Bedich offers a variety of cosmetic ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. ... of the HP3 (High-Performance Periodontal Practice) continuing education (CE) series. As a compassionate ... in his field by attending numerous CE courses each year. His recent course, ...
(Date:5/24/2017)... Brentwood, TN (PRWEB) , ... May 24, 2017 ... ... announced the addition of ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first ... and security of every IT system, from the datacenter to the cloud to ...
(Date:5/24/2017)... ... 2017 , ... Rob Lowe is a sought after actor, and also serves ... the public important topics from all aspects of life, and a new segment is ... feet and ankles. , Podiatry is essential to people’s overall well-being, and if viewers ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Technique, technique, ... back injury when either lifting weights for strength training and exercise or simply lifting ... Center . , “Body position is everything,” Dr. Chang says. “Improper technique in lifting ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: